These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35475247)

  • 1. Impact of Nicotine on Cognition in Patients With Schizophrenia: A Narrative Review.
    Spasova V; Mehmood S; Minhas A; Azhar R; Anand S; Abdelaal S; Sham S; Chauhan TM; Dragas D
    Cureus; 2022 Apr; 14(4):e24306. PubMed ID: 35475247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.
    Ochoa EL; Lasalde-Dominicci J
    Cell Mol Neurobiol; 2007 Aug; 27(5):609-39. PubMed ID: 17554626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.
    Fowler CD; Arends MA; Kenny PJ
    Behav Pharmacol; 2008 Sep; 19(5-6):461-84. PubMed ID: 18690103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.
    Boggs DL; Carlson J; Cortes-Briones J; Krystal JH; D'Souza DC
    Curr Pharm Des; 2014; 20(31):5077-92. PubMed ID: 24345265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.
    Mihailescu S; Drucker-Colín R
    Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex.
    Wallace TL; Bertrand D
    Biochem Pharmacol; 2013 Jun; 85(12):1713-20. PubMed ID: 23628449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.
    Hendrickson LM; Guildford MJ; Tapper AR
    Front Psychiatry; 2013; 4():29. PubMed ID: 23641218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying behaviors related to nicotine addiction.
    Picciotto MR; Kenny PJ
    Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012112. PubMed ID: 23143843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.
    D'Souza MS; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1564-73. PubMed ID: 21288470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Parikh V; Kutlu MG; Gould TJ
    Schizophr Res; 2016 Mar; 171(1-3):1-15. PubMed ID: 26803692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking and Cognition.
    Campos MW; Serebrisky D; Castaldelli-Maia JM
    Curr Drug Abuse Rev; 2016; 9(2):76-79. PubMed ID: 27492358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of nicotine: genetic moderators.
    Herman AI; Sofuoglu M
    Addict Biol; 2010 Jul; 15(3):250-65. PubMed ID: 20456288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.
    Mineur YS; Picciotto MR
    Trends Pharmacol Sci; 2010 Dec; 31(12):580-6. PubMed ID: 20965579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
    Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
    JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine's effect on cognition, a friend or foe?
    Wang Q; Du W; Wang H; Geng P; Sun Y; Zhang J; Wang W; Jin X
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jun; 124():110723. PubMed ID: 36736944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine Addiction and Psychiatric Disorders.
    Kutlu MG; Parikh V; Gould TJ
    Int Rev Neurobiol; 2015; 124():171-208. PubMed ID: 26472530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.